Allogene Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALLO and other ETFs, options, and stocks.About ALLO
Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells.
ALLO Key Statistics
Stock Snapshot
Allogene Therapeutics(ALLO) stock is priced at $1.99, giving the company a market capitalization of 678.89M. It carries a P/E multiple of -2.96.
On 2026-09-05, Allogene Therapeutics(ALLO) stock moved within a range of $1.95 to $2.01. With shares now at $1.99, the stock is trading +2.0% above its intraday low and -1.0% below the session's peak.
Trading activity shows a volume of 4.43M, compared to an average daily volume of 4.74M.
The stock's 52-week range extends from a low of $1.04 to a high of $4.46.
The stock's 52-week range extends from a low of $1.04 to a high of $4.46.
ALLO News
...
Allogene Therapeutics (ALLO) announced that Geoffrey Parker, executive VP and CFO, will retire effective November 6. Parker will continue to lead the finance or...
Analyst ratings
91%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.